NICLOSAMIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for niclosamide and what is the scope of patent protection?
Niclosamide
is the generic ingredient in one branded drug marketed by Bayer Pharms and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for niclosamide.
Summary for NICLOSAMIDE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Clinical Trials: | 33 |
| Patent Applications: | 6,297 |
| DailyMed Link: | NICLOSAMIDE at DailyMed |
Recent Clinical Trials for NICLOSAMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Stanford University | Phase 1 |
| TFF Pharmaceuticals, Inc. | Phase 1 |
| Mahidol University | Phase 4 |
Medical Subject Heading (MeSH) Categories for NICLOSAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for NICLOSAMIDE
US Patents and Regulatory Information for NICLOSAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Pharms | NICLOCIDE | niclosamide | TABLET, CHEWABLE;ORAL | 018669-001 | May 14, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
